Skip to main content
SV108 · SV-Delivery™

SV108 Delivery™ Human NK cell targeted LNP

Not listed

开发中 · 联系 SunVax partnership

Species
Human
Primary target
NK cell (human)
Applications
in vitro (early)
Cargo compatibility
mRNA (early)
Particle size
—
Freeze-thaw cycles tested
—

Published efficacy

Each result is shown with its evidence grade and source. Grade D entries are not displayed in production.

AssayResultGradeSource
Balb/c NK cells in vivo (proxy)~5% GFP+ (NK 较 T cell 低)BSunVax conference 2026-05-03 slide 3
Order SV108 from SunVax ↗Partner with SunVax ↗Design my SV108 experiment →

Sources used on this page

  • SunVax conference presentation 2026-05-03 · slide 2 (kits portfolio) and slide 3 (efficacy / stability data).
  • SunVax product catalog at sunvaxmrna.com (last verified 2026-05-16).
  • Per-result citations are shown in the "Published efficacy" table above with their evidence grade.

To request a correction or to ask for additional documentation on this kit, email yingzhongli@sunvaxmrna.com.